Comparison of Dexmedetomidine Versus Midazolam as Premedication For Attenuation of Hemodynamic Response To Laryngoscopy And Intubation
International Journal of Current Pharmaceutical Review and Research · 28.02.2026 · 18 (02)
DOI: 10.25258/ijcpr.18.2.342 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 28.02.2026. Verfasst von Deepshikha Deepshikha und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Significant sympathetic activation during laryngoscopy and endotracheal intubation is linked to tachycardia and hypertension. Particularly in patients with cardiovascular comorbidities, these hemodynamic reactions may raise perioperative morbidity. Premedication with sympatholytic and sedative medications is crucial for reducing these reactions.
Aim
To compare the efficacy of dexmedetomidine and midazolam as premedication agents for attenuation of hemodynamic response to laryngoscopy and intubation. Materials and Methods: This prospective comparative study was conducted at Nalanda Medical College and Hospital from March 2025 to November 2025. Ninety adult patients aged 18–60 years belonging to ASA grade I and II undergoing elective surgery under general anesthesia were included. Patients were randomly divided into two groups of 45 each. Group D received intravenous dexmedetomidine 1 µg/kg infusion, while Group M received intravenous midazolam 0.05 mg/kg before induction. Hemodynamic parameters including heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were recorded at baseline, after premedication, during laryngoscopy, and after intubation. The Chi-square test and Student's ttest were used for statistical analysis. Statistical significance was defined as a p-value of less than 0.05.
Results
Patients receiving dexmedetomidine demonstrated significantly lower heart rate and blood pressure responses during laryngoscopy and intubation compared to the midazolam group. Mean heart rate during intubation was 82.4 ± 7.1 bpm in Group D compared to 96.8 ± 8.5 bpm in Group M (p < 0.001). Mean systolic blood pressure during intubation was significantly lower in Group D (124.6 ± 9.2 mmHg) compared to Group M (138.2 ± 10.1 mmHg; p < 0.001). Similar significant reductions were observed in DBP and MAP. Dexmedetomidine provided superior attenuation of sympathetic response with better perioperative hemodynamic stability.
Conclusion
Dexmedetomidine is more effective than midazolam in attenuating hemodynamic responses to laryngoscopy and endotracheal intubation. Its sympatholytic and sedative properties provide superior cardiovascular stability during induction of anesthesia.
Zitieren
APA
Deepshikha, D., Amber, K. N., Kumar, M., & Kumar, B. (2026). Comparison of Dexmedetomidine Versus Midazolam as Premedication For Attenuation of Hemodynamic Response To Laryngoscopy And Intubation. International Journal of Current Pharmaceutical Review and Research, 18(02). https://doi.org/10.25258/ijcpr.18.2.342
Vancouver
Deepshikha D, Amber KN, Kumar M, Kumar B. Comparison of Dexmedetomidine Versus Midazolam as Premedication For Attenuation of Hemodynamic Response To Laryngoscopy And Intubation. International Journal of Current Pharmaceutical Review and Research. 2026;18(02). doi:10.25258/ijcpr.18.2.342
BibTeX
@article{Deepshikha2026,
author = {Deepshikha, Deepshikha and Amber, Kumar Nishant and Kumar, Mukesh and Kumar, Bijoy},
title = {Comparison of Dexmedetomidine Versus Midazolam as Premedication For Attenuation of Hemodynamic Response To Laryngoscopy And Intubation},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {02},
doi = {10.25258/ijcpr.18.2.342}
}
EUVIMED